Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.
- Citation:
- Cancer vol 107 (12) 2817-25
- Year:
- 2006
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA02599, CA03927, CA04326, CA04457, CA07968, CA08025, CA11789, CA12046, CA16450, CA26806, CA31946, CA31983, CA33601, CA35279, CA41287, CA47555, CA47559, CA47577, CA47642, CA77597, CA77658
- Corr. Author:
- Authors:
- Kristie A Blum Jeffrey L Johnson Donna Niedzwiecki Lawrence D Piro Alan Saven Bruce A Peterson John C Byrd Bruce D Cheson
- Networks:
- Study
- CALGB-9153
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adolescent, Adult, Antineoplastic Agents, Cladribine, Female, Follow-Up Studies, Humans, Lymphoma, Non-Hodgkin, Male, Middle Aged, Neoplasm Staging, Treatment Outcome